Trial Profile
First-in-human trial of LJN-452 for the treatment of non-alcoholic steatohepatitis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Aug 2015
Price :
$35
*
At a glance
- Drugs Tropifexor (Primary)
- Indications Non-alcoholic steatohepatitis
- Focus Adverse reactions
- 18 Aug 2015 New trial record